Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
- Program Focuses on Expanding Pipeline of Drugs For People with Type 1 Diabetes -
NEW YORK, Aug. 5 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation said today that it has entered into a novel collaborative research agreement with the Genomics Institute
National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness
SEATTLE, July 21 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (Nasdaq and MTA: CTIC) announced today that researchers from the Laboratory of Molecular Pharmacology at the National Cancer Institute
presented new preclinical research identifying unique anti-tumor mechanisms of br...
Lupus Research Institute Highly Encouraged by Benlysta(TM) Trial Results
First Phase 3 Lupus Drug Trial in Decades to Show Effectiveness
NEW YORK, July 20 /PRNewswire-USNewswire/ -- The Lupus Research Institute
(LRI) and its National Coalition of state and local organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline on the high...
International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
DETROIT, July 20 /PRNewswire-USNewswire/ -- Scientists at the Barbara Ann Karmanos Cancer Institute's National Center for Vermiculite and Asbestos-Related Cancers (NCVAC) have discovered a probable reason for the unrelenting chest pain experienced in certain patients with asbestos-r...
CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
VIENNA, Va., July 10 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM ), a late stage cancer immunotherapy company, announced today that Dr. Eyal Talor, CEL-SCI's Senior Vice President of Research and Manufacturing, has been invited to present to the NIH, NCI's Clinical Cent...
USC Keck School of Medicine's Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic
LOS ANGELES, July 7 /PRNewswire-USNewswire/ -- The University of Southern California today announced that Dr. Alan Epstein of the USC Keck School of Medicine has received approval for a $3.5 million drug development project through the Rapid Access to Intervention Development (RAID) program of...
SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts
- Thirteen Renowned Medical Experts Slated to Attend First National Symposium -
CORTLAND, N.Y., June 25 /PRNewswire/ -- The first national symposium designed to explore the health impacts of energy drinks will be held next week in New York City when thirteen top experts gather to present rese...
West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial
Collaboration will test remote wireless monitoring to prevent hospital readmissions for heart failure
SAN DIEGO, June 24 /PRNewswire-USNewswire/ -- The West Wireless Health Institute
(WWHI), one of the world's first medical research organizations dedicated to advancing health and well-being t...
Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
Florida's First Three-Year Neuroscience Research Doctorate Program
SARASOTA, Fla., June 18 /PRNewswire/ -- Sarasota's Roskamp Institute
(Roskamp) today announced the first enrollment of students in its pioneering three-year Ph.D. program through which students will conduct full-time laborator...
Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
SAN FRANCISCO, June 11 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Canada), a clinical-stage biopharmaceutical company, announced today that a $10 million grant from the Ontario Institute
for Cancer Research (OICR) has been received by the Centre for Cancer Therapeutics at Ottawa...
ThermoGenesis Announces National Institute of Health Grant
COMPANY'S FIRST-EVER NIH GRANT WILL BE USED TO DEVELOP CELL DELIVERY TECHNOLOGIES FOR REGENERATIVE MEDICINE APPLICATIONS
RANCHO CORDOVA, Calif., June 9 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products for processing and storing adult s...
Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative
Abstract # 6053
ORLANDO, Fla., June 1 /PRNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute
in Detroit presented data demonstrating the feasibility of long-term, low-dose adjuvant chemotherapy, which resulted in fewer tumor recurrences and cancer metastases in patients wit...
Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
Abstract # 25670
ORLANDO, Fla., May 29 /PRNewswire-USNewswire/ -- The American Society of Clinical Oncology (ASCO) has selected new breast cancer research conducted at the Barbara Ann Karmanos Cancer Institute
in Detroit for posting on ASCO's Web site. Karmanos' potentially ground-breaking fi...
Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimer's Disease
MORGANTOWN, W.Va., May 27 /PRNewswire-USNewswire/ -- The Blanchette Rockefeller Neurosciences Institute
(BRNI) and Inverness Medical Innovations, Inc. (Inverness, NYSE: IMA ) of Waltham, Massachusetts, a global leader in rapid diagnostics and health management, announced today that they will work...
Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ)
Do-It-Yourself exercises help reduce stress-related TMJ problems and create healthy, pain-free habits
BERKELEY, Calif., May 18 /PRNewswire/ -- The Feldenkrais Movement Institute
announces the release of The Intelligent Body(R) TMJ Program as part of its The Intelligent Body(R) DIY-ser...
Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
TAMPA, Fla., May 5 /PRNewswire-USNewswire/ -- The Tampa Lions Eye Institute
for Transplant and Research, Inc. (LEITR) today announced plans to open a new 12,000-square-foot facility in Tampa, Florida. This state-of-the-art facility will offer high-volume, high-quality human ocular tissue for resea...
Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
DENVER, April 21 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute
in Detroit presented data today at the American Association for Cancer Research's 100th Annual Meeting 2009 that could potentially provide a brighter future for children who su...
Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
Abstract # 2905
DENVER, April 20 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute
in Detroit today presented data at the American Association for Cancer Research's 100th Annual Meeting 2009 that represents significant research advancements in the treatment ...
Midwest Research Institute Launches Clinical Molecular Diagnostics Laboratory
Receives CLIA Certification and CAP Accreditation
PALM BAY, Fla., April 17 /PRNewswire-USNewswire/ -- To address the growing need for molecular diagnostics, officials at the Florida Division of Midwest Research Institute
(MRI) announced today that they have established a Clinical Molecular Di...
Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
SEATTLE, Jan. 28 /PRNewswire/ -- Omeros Corporation today announced that it was awarded $3.1 million in a second tranche of equity and grant funding from The Stanley Medical Research Institute
(SMRI) to support late-stage preclinical development of the Company's proprietary product candidates for ...
Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach
ROCKVILLE, Md. and NEW YORK, Jan. 27 /PRNewswire-USNewswire/ -- Researchers from the J. Craig Venter Institute
(JCVI) and the Ludwig Institute
for Cancer Research (LICR) have uncovered new genomic alterations that lead to gene fusions in a breast cancer cell line by using 454 Life Sciences sequenc...
Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease
Research Uncovers New Link Between Inflammation & Alzheimer's Disease
SARASOTA, Fla., Dec. 16 /PRNewswire/ -- The Roskamp Institute
today announced that its researchers have uncovered a new link between inflammation and Alzheimer's disease and have identified a potential target for de...
Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease
MIAMI, Nov. 12 /PRNewswire/ -- The Miami Jewish Home and Hospital,
Berma Research Group, and Segal Institute
for Clinical Research today
announced that they are actively enrolling patients in the CONNECTION
study, a Phase 3 clinical trial that is evaluating the safety and efficacy
of the inves...
Texas Back Institute Leads Way in New Facet Joint Clinical Trial
TBI is first and only participant in Texas for TFAS spinal implant
PLANO, Texas, Nov. 6 /PRNewswire/ -- Texas Back Institute
the way again in motion preserving technology by continuing to advance
spinal device studies with a clinical trial of the Total Facet Arthroplasty
Sarah Cannon Research Institute Selects OmniComm Systems' Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
Renowned cancer research center enters into a Technology Transition
agreement with OmniComm to gain more control over the management of their clinical trials
FT. LAUDERDALE, Fla., Nov. 4 /PRNewswire-FirstCall/ -- OmniComm
Systems, Inc. (OTC Bulletin Board: OMCM.OB...
Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
AUSTIN, Texas, Oct. 7 /PRNewswire/ -- The Texas Cardiac Arrhythmia
Institute (TCAI) at St. David's Medical Center has been selected as one of
only a few sites in the nation to participate in an FDA-approved clinical
trial for a new device to treat persistent atrial fibrillation. TCAI, an
Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
MOUNTAIN VIEW, Calif. and SEATTLE, Oct. 6 /PRNewswire/ -- Complete
Genomics Inc., a newly launched, third-generation human genome sequencing
company, and the Institute
for Systems Biology (ISB) today announced their
partnership to conduct populationwide human genome studies.
In phase one of ...
Agendia's MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines
HUNTINGTON BEACH, Calif., and AMSTERDAM, Netherlands, Sept. 18
/PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics,
today announced that its signature breast cancer tumor recurrence test,
MammaPrint(R), has been included in the updated 2008 guidelines of The
Omeros and The Parkinson's Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
SEATTLE and SUNNYVALE, Calif., Sept. 17 /PRNewswire/ -- Omeros
Corporation and The Parkinson's Institute
and Clinical Center today
announced that they have entered into a collaboration to evaluate a novel
target, proprietary to Omeros, for the treatment of movement disorders. The
DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
DETROIT, Sept. 15 /PRNewswire-USNewswire/ -- Researchers at the Barbara
Ann Karmanos Cancer Institute
and Wayne State University School of Medicine
have developed a HER2 DNA vaccine that has shown to be effective on drug
resistant tumors in mice. The study was reported in the September 15 issu...
Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network
BIRMINGHAM, Ala., Sept. 4 /PRNewswire/ -- Southern Research Institute
today announced that the National Institutes of Health (NIH) has selected
the organization to participate in the newly-funded Molecular Libraries
Probe Production Center Network (MLPCN). The MLPCN -- a collaborative
Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
Could Be Life-Changing for Stroke, Traumatic Brain Injury, Alzheimer's Patients
MORGANTOWN, W.Va., Sept. 1 /PRNewswire-USNewswire/ -- Scientists at the
Blanchette Rockefeller Neurosciences Institute
(BRNI) have discovered that
Bryostatin -- and a related class o...
Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- Vical Incorporated
(Nasdaq: VICL ) today announced a research collaboration with the Karolinska
Institutet (KI), a leading European medical university, and the Swedish
Institute for Infectious Disease Control (SMI), a governmental expert
ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease
Donated blood and tissue samples to be used to identify molecular
signature of motor neuron disease
CAMBRIDGE, Mass., Aug. 19 /PRNewswire-USNewswire/ -- ALS Therapy
(ALS TDI) announced today the acceleration of an ALS
biomarker effort using blood samples collected throug...
Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- Vical Incorporated
(Nasdaq: VICL ) today announced a research collaboration with the Karolinska
Institute, a leading European medical university, and the Swedish Institute
for Infectious Disease Control (SMI), a governmental expert agency, to
MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
SAN DIEGO, Aug. 12 /PRNewswire/ -- MabVax Therapeutics, Inc., a
privately held immunotherapeutics discovery and development company focused
on the development and commercialization of novel immunotherapies for the
treatment of cancer, today announced the completion of two separate
Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
SEATTLE and ATLANTA, July 30 /PRNewswire/ -- A patient with pancreatic
cancer recently became the first person in the United States to receive
treatment using Elekta VMAT (Volumetric intensity Modulated Arc Therapy) at
Seattle's Swedish Cancer Institute. This revolutionary new technology
GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
Data being made available on NCI Database Could Save Drug Development Time and Capital for Other Research Institutions
PHILADELPHIA, June 20 /PRNewswire-FirstCall/ -- Marking another
positive step in the collaborative fight against cancer, GlaxoSmithKline
(NYSE: GSK ) announced to...
Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease
- Data from Pivotal Study Highlighted at Recent Arizona Alzheimer's Consortium Annual Conference in Phoenix -
PHOENIX and SUN CITY, Ariz., June 9 /PRNewswire/ -- Banner Alzheimer's
Institute and Sun Health Research Institute
today announced that they are
actively enrolling pati...
Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
CHICAGO, June 1 /PRNewswire/ -- Researchers at the Barbara Ann Karmanos
in Detroit today presented findings that show
immunotherapy with armed targeted T cells may improve the overall survival
of women with metastatic breast cancer.